Background
Methods
Search strategy
Inclusion criteria | Exclusion criteria |
---|---|
• Study settings: conducted in Ethiopian on any settings • Study subjects/population: humans • Study design: any study reported the prevalence of VRE or numbers of VRE and total enterococci isolates • Sample size: studies isolated not less than two enterococci • Language: published/reported in English • Type of study: peer-reviewed, full text available before June 30, 2019 | • Studies on antimicrobial susceptibility tests other than vancomycin (studies that did not include VRE) • Prevalence studies only • Studies having less than two isolates • Studies not reporting enterococcal isolates separately (no population denominator) • Reviews, comments and duplications • Studies on non-human subjects |
Quality assessment
Data extraction
Data analysis
Results
Study selection
Characteristics of included studies
Author, publication year | Study period | Study area/ region | Study design | Study subjects | Sample size | Prevalence of enterococci, N (%) | Type of specimen | AST method | Prevalence of VRE, N (%) | Types of isolates (species) | Publication history |
---|---|---|---|---|---|---|---|---|---|---|---|
Abamecha, 2015 [48] | January to July 2013 | Jima University Specialized Hospital, Oromia | CS | Hospitalized patients | 150 | 114 (76.00) | Stool, rectal swabs | Disc diffusion, MIC for VRE | 2 (1.8) | E.faecium, E.faecalis, E.gallinarum, E.casseliflavus, E.durans | Published |
Abebe, 2014 [37] | July to September 2013 | University of Gondar Teaching Hospital, Amhara | CS | HIV positive and HIV negative clients | 226 | 201 (88.94) | Stool | Disc diffusion | 11 (5.5) | Not identified to species level | Published |
Agegne, 2018 [36] | February to May 2017 | West Amhara Hospitals, Amhara | CS | HIV patients on ART | 349 | 220 (63.04) | Stool | Disc diffusion | 17 (7.7) | Not identified to species level | Published |
Ali, 2018 [35] | February to May, 2017 | Dessie Referral Hospital, Amhara | CS | HIV positive and HIV negative clients | 300 | 112 (37.33) | Stool | Disc diffusion | 7 (6.3) | Not identified to species level | Published |
Ayelign, 2018 [33] | February to June 2015 | University of Gondar Hospital, Amhara | CS | Pediatric patients | 310 | 3 (0.97) | Urine | Disc diffusion | 1 (33.3) | Not identified to species level | Published |
Birri, 2013 [23] | Not reported | Dilla town, SNNPR | CS | Healthy infants aged 3 to 26 weeks | 28 | 53 (189.29)a | Stool | Dilution/MIC | 1 (1.9) | E.faecium, E.faecalis, E.avium, E.canintestini, E.maldoratus, E.raffinosus, E.gallinarum | Published |
Eshetu, 2017 [44] | April to September 2016 | Tikur Anbessa Specialized Hospital, Addis Ababa | CS | Blood stream infection suspects | 422 | 5 (1.18) | Blood | Disc diffusion | 3 (60.0) | Not identified to species level | Unpublished |
Fentie, 2018 [32] | February to April 2017 | University of Gondar teaching Hospital, Amhara | CS | Cancer patients | 216 | 2 (0.93) | Blood, urine, wound swab, ear discharge | Disc diffusion | 1 (50.0) | Not identified to species level | Published |
Ferede, 2018 [41] | April to May 2016 | Black Lion/Tikur Anbesa Specialized Hospital, Addis Ababa | CS | Patients suspected for UTI, wound infection, septicemia, endocarditis, meningitis | 422 | 15 (3.55) | Blood, urine, body fluid, CSF, Pus | Disc diffusion | 1 (6.7) | Not identified to species level | Published |
Gebrish, 2019 [47] | February to March 2016 | Jimma University Specialized Hospital, Oromia | CS | Hospitalized pediatric patients | 52 | 12 (23.08) | Stool, rectal swabs | Disc diffusion | 1 (8.3) | E.faecalis, E.faecalis, E.gallinarum | Published |
Jemal, 2017 [34] | July to December 2016 | Felege Hiwot Referral Hospital, Amhara | CS | HIV patients on ART | 384 | 4 (1.04) | Blood | Disc diffusion | 0.5b (10.0) | Not identified to species level | Unpublished |
Lega, 2015 [42] | April to July 2015 | Yekatit 12 Hospital Medical College, Addis Ababa | CS | Diabetic patients | 246 | 2 (0.81) | Urine | Disc diffusion | 1 (50.0) | Not identified to species level | Unpublished |
Mitiku, 2018 [40] | September 2017 to June 2018 | Tikur Anbesa Specialized Hospital, Addis Ababa | CS | Under 5 children with febrile illness | 340 | 11 (3.24) | Blood | Disc diffusion | 0.5b (4.2) | Not identified to species level | Unpublished |
Mohammed, 2017 [31] | March to May, 2014 | University of Gondar Referral Hospital, Amhara | CS | Patients with wound infections | 137 | 2 (1.46) | Wound swab | Disc diffusion | 1 (50.0) | Not identified to species level | Published |
Molalign, 2016 [39] | September 2015 to May 2016 | Arsho Advanced Medical laboratory, Addis Ababa | CS | UTI patients | 712 | 15 (2.11) | Urine | Dilution/MIC | 7 (46.7) | E.faecalis, E.gallinarum | Unpublished |
Sorsa, 2019 [46] | April 2016 to May 2017 | Asella teaching and referral hospital, Oromia | CS | Neonates with sepsis | 303 | 6 (1.98) | Blood | Disc diffusion | 1 (16.7) | Not identified to species level | Published |
Teklehaymanot, 2016 | July to September 2015 | Tikur Anbessa Specialized Hospital, Addis Ababa | CS | Patients suspected for body fluid pathogens | 384 | 2 (0.52) | CSF, ascites, pleural fluid, synovial fluid | Disc diffusion | 0.5 b (16.7) | Not identified to species level | Unpublished |
Toru, 2018 [45] | April to September 2016 | Jimma University Specialized Hospital, Oromia | CS | Pediatric patients (< 15 years) | 403 | 22 (5.46) | Urine, blood, swabs, closed abscess, body fluids, CSF | Disc diffusion | 5 (22.7) | Not identified to species level | Published |
Woldemariam, 2019 [38] | April to July 2015 | St. Paul Specialized Hospital Millennium Medical College, Addis Ababa | CS | Adult diabetic patients | 248 | 6 (2.42) | Urine | Disc diffusion | 1 (16.7) | Not identified to species level | Published |
Yilema, 2017 [30] | February to May 2014 | University of Gondar Teaching Hospital, Amhara | CS | Patients requiring culture and AST | 385 | 24 (6.23) | Urine, blood, wound swabs, ear discharge, ascites, abscess | Disc diffusion | 10 (41.7) | Not identified to species level | Published |
Pooled prevalence of VRE
Subgroup prevalence of VRE
Subgroups | Numbers of studies | No of enterococci isolates tested, N | Pooled prevalence of VRE, N (%) | 95% CI | I2 | P-value |
---|---|---|---|---|---|---|
Region | ||||||
Addis Ababa | 7 | 56 | 13 (26.1) | 10.7–50.9 | 41.65 | 0.113 |
Amhara | 8 | 568 | 38 (15.0) | 6.9–29.6 | 79.39 | < 0.001 |
Oromia | 4 | 154 | 19 (9.0) | 2.8–25.7 | 71.49 | 0. 015 |
SNNPR | 1 | 53 | 1 (1.9) | 0.8–19.8 | – | – |
Study perioda | ||||||
Before/in 2015 | 8 | 354 | 27 (16.5) | 6.5–31.5 | 81.09 | < 0.001 |
After 2015 | 11 | 424 | 43 (16.3) | 7.6–31.3 | 69.20 | < 0.001 |
AST method | ||||||
Disc diffusion | 17 | 649 | 61 (16.9) | 9.3–28.9 | 66.89 | < 0.001 |
Dilution/MIC | 3 | 182 | 10 (7.9) | 1.9–27.6 | 91.88 | < 0.001 |
Type of specimen | ||||||
Stool | 5 | 598 | 37 (5.9) | 2.8–11.7 | 0.00 | 0.629 |
Urine | 4 | 26 | 10 (37.3) | 15.8–63.3 | 0.00 | 0.665 |
Blood | 4 | 26 | 4 (22.0) | 6.9–51.9 | 45.06 | 0.141 |
Wound swab | 1 | 2 | 1 (50.0) | – | – | – |
Multi-siteb | 6 | 179 | 19 (16.8) | 8.0–31.9 | 77.87 | < 0.001 |
Publication history | ||||||
Published | 14 | 792 | 60 (11.3) | 6.4–19.2 | 72.86 | < 0.001 |
Unpublished | 6 | 39 | 11 (31.9) | 12.9–59.7 | 25.82 | 0.241 |
Antimicrobial resistant enterococci
Antibiotics | No of studies | No of enterococci isolates tested, N | Pooled resistance N, (%) | 95% CI | I2 (%) | P-value |
---|---|---|---|---|---|---|
Amoxicillin | 2 | 203 | 115 (56.5) | 49.6–63.2 | 0.00 | 0.382 |
Amox-clavulanate | 2 | 225 | 71 (45.3) | 13.9–80.9 | 92.37 | < 0.001 |
Ampicillin | 16 | 807 | 344 (44.5) | 29.2–61.0 | 90.83 | < 0.001 |
Chloramphenicol | 12 | 777 | 188 (32.9) | 20.8–47.8 | 87.24 | < 0.001 |
Ceftriaxone | 2 | 8 | 4 (50.0) | 20.0–80.0 | 0.00 | > 0.05 |
Ciprofloxacin | 17 | 765 | 266 (36.5) | 27.0–47.3 | 75.30 | < 0.001 |
Clindamycin | 4 | 224 | 59 (26.9) | 21.5–33.2 | 0.00 | 0.478 |
Daptomycin | 2 | 29 | 0.5 (3.2)a | 0.5–19.7 | 0.00 | 0.974 |
Doxycycline | 3 | 254 | 85 (55.1) | 22.2–84.0 | 90.21 | < 0.001 |
Erythromycin | 14 | 780 | 374 (49.6) | 36.5–62.7 | 86.19 | < 0.001 |
Gentamycin | 10 | 533 | 248 (37.7) | 22.2–56.1 | 88.86 | < 0.001 |
Linezolid | 2 | 30 | 2 (9.9) | 2.8–29.0 | 0.00 | 0.336 |
Nitrofurantoin | 9 | 404 | 117 (31.5) | 23.4–41.0 | 38.76 | 0.110 |
Norfloxacin | 5 | 350 | 100 (39.9) | 18.6–66.6 | 90.21 | < 0.001 |
Penicillin | 8 | 343 | 181 (60.7) | 39.9–78.3 | 86.63 | < 0.001 |
Streptomycin | 3 | 179 | 74 (36.8) | 10.4–73.1 | 91.62 | < 0.001 |
Tetracycline | 9 | 450 | 199 (53.7) | 35.8–70.7 | 86.95 | < 0.001 |
SXT | 10 | 241 | 104 (39.1) | 21.48–59.6 | 45.58 | 0.088 |
MDR - enterococci | 20 | 825 | 543 (60.0) | 42.9–75.0 | 90.27 | < 0.001 |